GLAXoSmithKline Intellectual Property Development Limited
发明人:
Xiao Ding,Qian Liu,Yingxia Sang,Luigi Piero Stasi,Zehong Wan,Baowei Zhao,Colin Michael Edge
申请号：
US16052791
公开号：
US20180354956A1
申请日:
2018.08.02
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of or prevention of diseases characterized by LRRK2 kinase activity, for example Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS).
